As expected, CD8+ T cell depletion reduced the anti-tumor effects of RT (Figure 6A & 6B-triangles), but more importantly, it rendered CVC therapy completely ineffective on enhancing the efficacy of RT as tumor burden was identical between CVC and vehicle treated mice in the absence of CD8+ T cells (Figure 6B-triangles). The gene discussed is CD8A; the disease is neoplasm.